ArticleChina CDC weekly2025
The iCARE-DM Model for Five-Year T2DM Risk Prediction in the Elderly Population from Chinese Routine Public Health Services - China, 2017-2024.
Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Risk assessment for high-risk populations is critical for preventing Type 2 Diabetes Mellitus (T2DM). Although China's public health services have continuously contributed to early grass-roots diagnosis of diabetes for years, universally applicable tools for identifying latent high-risk elderly populations urgently need to account for heterogeneity, robustness, and generalizability. Therefore, this study developed and validated the integrated Chinese Adapted Risk Evaluation for Diabetes Mellitus (iCARE-DM) model for elderly Chinese individuals. Methods: The iCARE-DM model was developed based on pooled effect estimates from a meta-analysis of cohort studies that identified T2DM risk factors in East Asian populations and validated in three multicenter Chinese populations. Predictive performance was evaluated using area under the curve (AUC), sensitivity, specificity, accuracy, log-rank tests, and compared with the guideline-recommended model (i.e., New Chinese Diabetes Risk Score, NCDRS) as well as four machine learning (ML) models. Results: The iCARE-DM model achieved AUC values of 0.741, 0.783, and 0.766, outperforming the NCDRS model by at least 12%. Although the best-performing ML model achieved AUC values comparable to the iCARE-DM model, its performance varied significantly across populations (with a range as high as 9%). Subgroup analyses of the iCARE-DM model confirmed consistent performance across age, gender and rural-urban groups. Conclusion: The iCARE-DM model demonstrated higher accuracy than the NCDRS model and exhibited superior robustness and generalizability compared to the ML models. The iCARE-DM model provides a robust, culturally adapted tool for T2DM risk assessment in elderly Chinese individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.